Viewing Study NCT00343356

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-01-27 @ 12:28 PM
Study NCT ID: NCT00343356
Status: COMPLETED
Last Update Posted: 2006-06-22
First Post: 2006-06-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder
Sponsor: LanZhou University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bladder neoplasm; View
None Carcinoma; View
None Epirubicin; View
None BCG; View
None Perfusion View